Gabriel Fenteany

Find an error

Name:
Organization: University of Connecticut
Department: Department of Chemistry
Title:
Co-reporter:Anniefer N. Magpusao, George Omolloh, Joshua Johnson, José Gascón, Mark W. Peczuh, and Gabriel Fenteany
ACS Chemical Biology 2015 Volume 10(Issue 2) pp:561
Publication Date(Web):October 21, 2014
DOI:10.1021/cb500665r
The cardiac glycosides ouabain and digitoxin, established Na+/K+ ATPase inhibitors, were found to inhibit MDA-MB-231 breast cancer cell migration through an unbiased chemical genetics screen for cell motility. The Na+/K+ ATPase acts both as an ion-transporter and as a receptor for cardiac glycosides. To delineate which function is related to breast cancer cell migration, structure–activity relationship (SAR) profiles of cardiac glycosides were established at the cellular (cell migration inhibition), molecular (Na+/K+ ATPase inhibition), and atomic (computational docking) levels. The SAR of cardiac glycosides and their analogs revealed a similar profile, a decrease in potency when the parent cardiac glycoside structure was modified, for each activity investigated. Since assays were done at the cellular, molecular, and atomic levels, correlation of SAR profiles across these multiple assays established links between cellular activity and specific protein–small molecule interactions. The observed antimigratory effects in breast cancer cells are directly related to the inhibition of Na+/K+ transport. Specifically, the orientation of cardiac glycosides at the putative cation permeation path formed by transmembrane helices αM1–M6 correlates with the Na+ pump activity and cell migration. Other Na+/K+ ATPase inhibitors that are structurally distinct from cardiac glycosides also exhibit antimigratory activity, corroborating the conclusion that the antiport function of Na+/K+ ATPase and not the receptor function is important for supporting the motility of MDA-MB-231 breast cancer cells. Correlative SAR can establish new relationships between specific biochemical functions and higher-level cellular processes, particularly for proteins with multiple functions and small molecules with unknown or various modes of action.
Co-reporter:Nicholas A. Eddy;Jay J. Richardson
European Journal of Organic Chemistry 2013 Volume 2013( Issue 23) pp:5041-5044
Publication Date(Web):
DOI:10.1002/ejoc.201300706

Abstract

Exposure of 3,3,6-trimethylcyclohex-5-ene-1,2,4-trione to catalytic amounts of Lewis acids revealed two disparate reactions in the presence of cyclopentadiene. The expected cycloaddition was found to be reversible for the title compound, and transfer hydrogenation was the preferred pathway over long periods of time. Other tested substrates were able to undergo facile cycloaddition with considerable yields and without the parallel reduction.

Co-reporter:Nicholas A. Eddy, Christopher B. Kelly, Michael A. Mercadante, Nicholas E. Leadbeater, and Gabriel Fenteany
Organic Letters 2012 Volume 14(Issue 2) pp:498-501
Publication Date(Web):December 29, 2011
DOI:10.1021/ol2030873
Here we describe the oxidation of 1,3-cyclohexanediones with 4-acetamido-2,2,6,6-tetramethylpiperidine-1-oxoammonium tetrafluoroborate (Bobbitt’s salt) to generate 5-ene-1,2,4-triones in moderate-to-good (40–80%) yields. This inexpensive oxidant facilitated an unprecedented cascade of oxidation and elimination to yield novel ene-triketones. The reactivity of these products was explored in the Diels–Alder reaction and provided moderate-to-good yields of cycloaddition products. The products described in this study represent unique, densely functionalized, and versatile building blocks for the synthesis of more complex molecules.
Co-reporter:Dr. Zhiming Wang;Dr. Sabrina Castellano;Dr. Sape S. Kinderman;Christian E. Argueta;Dr. Anwar B. Beshir; Gabriel Fenteany; Ohyun Kwon
Chemistry - A European Journal 2011 Volume 17( Issue 2) pp:649-654
Publication Date(Web):
DOI:10.1002/chem.201002195

Abstract

A library of 91 heterocyclic compounds composed of 16 distinct scaffolds has been synthesized through a sequence of phosphine-catalyzed ring-forming reactions, Tebbe reactions, Diels–Alder reactions, and, in some cases, hydrolysis. This effort in diversity-oriented synthesis produced a collection of compounds that exhibited high levels of structural variation both in terms of stereochemistry and the range of scaffolds represented. A simple but powerful sequence of reactions thus led to a high-diversity library of relatively modest size with which to explore biologically relevant regions of chemical space. From this library, several molecules were identified that inhibit the migration and invasion of breast cancer cells and may serve as leads for the development of antimetastatic agents.

Co-reporter:Anniefer N. Magpusao, Richard T. Desmond, Katelyn J. Billings, Gabriel Fenteany, Mark W. Peczuh
Bioorganic & Medicinal Chemistry Letters 2010 Volume 20(Issue 18) pp:5472-5476
Publication Date(Web):15 September 2010
DOI:10.1016/j.bmcl.2010.07.083
The biological activities of a family of novel, lipid-linked 13-membered-ring macro-dilactones are reported. These [13]-macro-dilactones were synthesized by diacylation of functionalized diols, followed by ring-closing metathesis under conditions we had previously reported. Antimigratory, cytostatic and cytotoxic activities of the compounds against cancer cells were evaluated. Compound 13 was the most potent in the series, while compound 10 had the broadest concentration range of subtoxic antiproliferative activity. These compounds share common structural components, namely the [13]-macro-dilactone templated by an octyl α-glucoside 4,6-diol.
Co-reporter:Kevin T. Mc Henry;Roberto Montesano;Shoutian Zhu;Anwar B. Beshir;Hui-Hui Tang;Kam C. Yeung
Journal of Cellular Biochemistry 2008 Volume 103( Issue 3) pp:972-985
Publication Date(Web):
DOI:10.1002/jcb.21470

Abstract

Raf kinase inhibitor protein (RKIP) regulates a number of cellular processes, including cell migration. Exploring the role of RKIP in cell adhesion, we found that overexpression of RKIP in Madin-Darby canine kidney (MDCK) epithelial cells increases adhesion to the substratum, while decreasing adhesion of the cells to one another. The level of the adherens junction protein E-cadherin declines profoundly, and there is loss of normal localization of the tight junction protein ZO-1, while expression of the cell–substratum adhesion protein β1 integrin dramatically increases. The cells also display increased adhesion and spreading on multiple substrata, including collagen, gelatin, fibronectin and laminin. In three-dimensional culture, RKIP overexpression leads to marked cell elongation and extension of long membrane protrusions into the surrounding matrix, and the cells do not form hollow cysts. RKIP-overexpressing cells generate considerably more contractile traction force than do control cells. In contrast, RNA interference-based silencing of RKIP expression results in decreased cell–substratum adhesion in both MDCK and MCF7 human breast adenocarcinoma cells. Treatment of MDCK and MCF7 cells with locostatin, a direct inhibitor of RKIP and cell migration, also reduces cell–substratum adhesion. Silencing of RKIP expression in MCF7 cells leads to a reduction in the rate of wound closure in a scratch-wound assay, although not as pronounced as that previously reported for RKIP-knockdown MDCK cells. These results suggest that RKIP has important roles in the regulation of cell adhesion, positively controlling cell–substratum adhesion while negatively controlling cell–cell adhesion, and underscore the complex functions of RKIP in cell physiology. J. Cell. Biochem. 103: 972–985, 2008. © 2007 Wiley-Liss, Inc.

Co-reporter:Alem W. Kahsai, Shoutian Zhu, Duncan J. Wardrop, William S. Lane, Gabriel Fenteany
Chemistry & Biology 2006 Volume 13(Issue 9) pp:973-983
Publication Date(Web):September 2006
DOI:10.1016/j.chembiol.2006.07.011
In the course of screening for new small-molecule modulators of cell motility, we discovered that quinocarmycin (also known as quinocarcin) analog DX-52-1 is an inhibitor of epithelial cell migration. While it has been assumed that the main target of DX-52-1 is DNA, we identified and confirmed radixin as the relevant molecular target of DX-52-1 in the cell. Radixin is a member of the ezrin/radixin/moesin family of membrane-actin cytoskeleton linker proteins that also participate in signal transduction pathways. DX-52-1 binds specifically and covalently to the C-terminal region of radixin, which contains the domain that interacts with actin filaments. Overexpression of radixin in cells abrogates their sensitivity to DX-52-1's antimigratory activity. Small interfering RNA-mediated silencing of radixin expression reduces the rate of cell migration. Finally, we found that DX-52-1 disrupts radixin's ability to interact with both actin and the cell adhesion molecule CD44.
Co-reporter:Alem W. Kahsai, Shoutian Zhu, Gabriel Fenteany
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (February 2010) Volume 1803(Issue 2) pp:
Publication Date(Web):February 2010
DOI:10.1016/j.bbamcr.2009.11.002
Ezrin/radixin/moesin (ERM) proteins are membrane-cytoskeleton linkers that also have roles in signal transduction. Here we show that G protein-coupled receptor kinase 2 (GRK2) regulates membrane protrusion and cell migration during wound closure in Madin-Darby canine kidney (MDCK) epithelial cell monolayers at least partly through activating phosphorylation of radixin on a conserved, regulatory C-terminal Thr residue. GRK2 phosphorylated radixin exclusively on Thr 564 in vitro. Expression of a phosphomimetic (Thr-564-to-Asp) mutant of radixin resulted in increased Rac1 activity, membrane protrusion and cell motility in MDCK cells, suggesting that radixin functions “upstream” of Rac1, presumably as a scaffolding protein. Phosphorylation of ERM proteins was highest during the most active phase of epithelial cell sheet migration over the course of wound closure. In view of these results, we explored the mode of action of quinocarmycin/quinocarcin analog DX-52-1, an inhibitor of cell migration and radixin function with considerable selectivity for radixin over the other ERM proteins, finding that its mechanism of inhibition of radixin does not appear to involve binding and antagonism at the site of regulatory phosphorylation.
2,16α,20,25-tetrahydroxy-9β-methyl-10α-19-norlanosta-1,5,23(E)-triene-3,11,22-trione
Cardanolide,3-[(6-deoxy-a-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-,(1b,3b,5b,11a,20x)-
Card-20(22)-enolide,1,3,5,11,14,19-hexahydroxy-, (1b,3b,5b,11a)-
Card-20(22)-enolide,3-[(6-deoxy-a-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-,(1b,3b,5b,11a)-